Patents by Inventor Nancy Paquette

Nancy Paquette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTIPLEX DETECTION OF VULVOVAGINAL CANDIDIASIS, TRICHOMONIASIS AND BACTERIAL VAGINOSIS
    Publication number: 20210332421
    Abstract: Methods and compositions for detection of vulvovaginal candidiasis (VVC), trichomoniasis and bacterial vaginosis (BV) are disclosed herein. In some embodiments, the presence or absence of VVC-associated Candida, Trichomonas vaginalis, and a plurality of BV-related bacteria in a sample is determined using multiplex nucleic acid-based testing methods.
    Type: Application
    Filed: July 8, 2021
    Publication date: October 28, 2021
    Inventors: Nancy Paquette, Marie-Helene Tremblay, Simon Tremblay, Roseline Therrien, Marie-Christine Fortin, Lucile Belley-Montfort, Dany Cantin, Celine Roger-Dalbert
  • Multiplex detection of vulvovaginal candidiasis, trichomoniasis and bacterial vaginosis
    Patent number: 11098376
    Abstract: Methods and compositions for detection of vulvovaginal candidiasis (VVC), trichomoniasis and bacterial vaginosis (BV) are disclosed herein. In some embodiments, the presence or absence of VVC-associated Candida, Trichomonas valginalis, and a plurality of BV-related bacteria in a sample is determined using multiplex nucleic acid-based testing methods.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: August 24, 2021
    Assignee: Becton, Dickinson and Company
    Inventors: Nancy Paquette, Marie-Helene Tremblay, Simon Tremblay, Roseline Therrien, Marie-Christine Fortin, Lucile Belley-Montfort, Dany Cantin, Celine Roger-Dalbert
  • MULTIPLEX DETECTION OF VULVOVAGINAL CANDIDIASIS, TRICHOMONIASIS AND BACTERIAL VAGINOSIS
    Publication number: 20180291431
    Abstract: Methods and compositions for detection of vulvovaginal candidiasis (VVC), trichomoniasis and bacterial vaginosis (BV) are disclosed herein. In some embodiments, the presence or absence of VVC-associated Candida, Trichomonas valginalis, and a plurality of BV-related bacteria in a sample is determined using multiplex nucleic acid-based testing methods.
    Type: Application
    Filed: April 20, 2016
    Publication date: October 11, 2018
    Inventors: Nancy Paquette, Marie-Helene Tremblay, Simon Tremblay, Roseline Therrien, Marie-Christine Fortin, Lucile Belley-Montfort, Dany Cantin, Celine Roger-Dalbert
  • Detection of toxigenic strains of
    Patent number: 9863007
    Abstract: Primers and probes for detection of toxin-producing (toxigenic) strains of Clostridium difficile, and to methods of detecting toxigenic strains using these primers and probes. Toxigenic strains of C. difficile are detected by nucleic acid-based amplification methods using particular primers and probes that bind to the toxin B (TcdB) gene. These primers and probes are used to amplify C. difficile nucleic acids in clinical samples to determine the presence of these toxigenic strains.
    Type: Grant
    Filed: June 26, 2015
    Date of Patent: January 9, 2018
    Assignee: Geneohm Sciences Canada, Inc.
    Inventors: Nancy Paquette, Marie-Eve Rochette, Rachel Labourdette
  • DETECTION OF TOXIGENIC STRAINS OF CLOSTRIDIUM DIFFICILE
    Publication number: 20150292004
    Abstract: Primers and probes for detection of toxin-producing (toxigenic) strains of Clostridium difficile, and to methods of detecting toxigenic strains using these primers and probes. Toxigenic strains of C. difficile are detected by nucleic acid-based amplification methods using particular primers and probes that bind to the toxin B (TcdB) gene. These primers and probes are used to amplify C. difficile nucleic acids in clinical samples to determine the presence of these toxigenic strains.
    Type: Application
    Filed: June 26, 2015
    Publication date: October 15, 2015
    Inventors: Nancy Paquette, Marie-Eve Rochette, Rachel Labourdette
  • Detection of toxigenic strains of
    Patent number: 9096638
    Abstract: Primers and probes for detection of toxin-producing (toxigenic) strains of Clostridium difficile, and to methods of detecting toxigenic strains using these primers and probes. Toxigenic strains of C. difficile are detected by nucleic acid-based amplification methods using particular primers and probes that bind to the toxin B (TcdB) gene. These primers and probes are used to amplify C. difficile nucleic acids in clinical samples to determine the presence of these toxigenic strains.
    Type: Grant
    Filed: September 3, 2008
    Date of Patent: August 4, 2015
    Assignee: GENEOHM SCIENCES CANADA, INC.
    Inventors: Nancy Paquette, Marie-Eve Rochette, Rachel Labourdette
  • DETECTION OF TOXIGENIC STRAINS OF CLOSTRIDIUM DIFFICILE
    Publication number: 20090208948
    Abstract: Primers and probes for detection of toxin-producing (toxigenic) strains of Clostridium difficile, and to methods of detecting toxigenic strains using these primers and probes. Toxigenic strains of C. difficile are detected by nucleic acid-based amplification methods using particular primers and probes that bind to the toxin B (TcdB) gene. These primers and probes are used to amplify C. difficile nucleic acids in clinical samples to determine the presence of these toxigenic strains.
    Type: Application
    Filed: September 3, 2008
    Publication date: August 20, 2009
    Applicant: Genohm Sciences Canada, Inc.
    Inventors: Nancy Paquette, Marie-Eve Rochette, Rachel Lobourdette